DCM
GSK icon

Driehaus Capital Management’s GSK GSK Stock Holding History

Driehaus Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-152,800
Closed -$8.81M – 541
2015
Q1 		$8.81M Buy
152,800
+8,000
+6% +$459K 0.31% 78
2014
Q4 		$7.74M Buy
+144,800
New +$8.1M 0.31% 75

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Driehaus Capital Management's GSK Position: Q2 2015 in Review

Driehaus Capital Management sold out of GSK (GSK) in Q2 2015, closing a stake of 152,800 shares — an estimated $8.81M sold.

Driehaus Capital Management first reported a position in GSK in Q4 2014 and held it in 2 quarters. The position peaked at $8.81M in Q1 2015. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

  • Driehaus Capital Management reported no remaining GSK position as of Q2 2015 after selling out during the quarter.
  • Driehaus Capital Management sold 152,800 GSK shares in Q2 2015, an estimated $8.81M.
  • Driehaus Capital Management first reported a position in GSK in Q4 2014 and held it in 2 quarters.
  • Driehaus Capital Management's GSK position peaked at $8.81M in Q1 2015.
  • 719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Driehaus Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.